@kevgo Jodele? Long time Alexion fan? KOLs are working with Omeros. FDA is helping getting Narsoplimab approved as fast as in every way they can. Rolling BLA is begun and completed in H1 2020 with clinical part as number 2 out of 3. So Q1 is a really good estimate for data. Also Omeros is hosting HSCT-TMA sessions at EBMT20 in Q1 so data will fit nice at that event
  • 5